JUNO THERAPEUTICS, created in 2013 (United States), from 126 sister brands and 17477 competing brands. The JUNO THERAPEUTICS brand is owned by Celgene, a company listed in New York. JUNO THERAPEUTICS is part of the Drug Manufacturers activity sector.